Immunoenzymatic assay of erbB2 protein in cancer and non-malignant breast tissue. Relationships with clinical and biochemical parameters

Anticancer Res. 1992 Nov-Dec;12(6B):2005-10.

Abstract

The erbB2-encoded protein p185 was determined in 130 breast cancer specimens and in 29 non-malignant breast tissues using a recently available ELISA method. The assay showed good characteristics of precision and accuracy. In the non-malignant tissue p185 concentrations were normally distributed and directly correlated with estrogen receptors (ER) and progesterone receptors (PR). In cancer tissue p185 showed higher concentrations than in non-malignant tissue. No relationships were found between p185 and the main clinical and pathological parameters, except that a direct association with nuclear grade was found. We have categorized the breast cancer samples according to p185 concentrations as p185-negative (concentrations lower than the higher non-malignant tissue) and p185-positive. Our data suggested a different behaviour of p185 in samples with low or high p185 concentrations. Indeed, in p185-negative samples the concentrations were directly correlated with both ER and PR. Conversely, p185-positive samples were directly associated with node status and pT, and inversely associated with ER and PR.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Biomarkers, Tumor / analysis*
  • Breast / chemistry
  • Breast / cytology
  • Breast / pathology*
  • Breast Neoplasms / chemistry
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / pathology*
  • Enzyme-Linked Immunosorbent Assay / methods
  • Female
  • Humans
  • Middle Aged
  • Proto-Oncogene Proteins / analysis*
  • Receptor, ErbB-2
  • Receptors, Estrogen / analysis
  • Receptors, Progesterone / analysis

Substances

  • Biomarkers, Tumor
  • Proto-Oncogene Proteins
  • Receptors, Estrogen
  • Receptors, Progesterone
  • Receptor, ErbB-2